Login
Recent Posts
- Fujirebio’s Diagnostic Test for Beta-amyloid Plaques Given FDA OK May 16, 2022
- Eisai Completes Rolling Submission to FDA for Lecanemab Approval May 12, 2022
- Treatment Lowers Toxic Amyloid-beta Levels in Mouse Brain Cells May 10, 2022
- FDA Committee to Review Nuplazid in Treating Alzheimer’s Psychosis May 9, 2022
- Biogen Scraps Infrastructure for Aduhelm Sales in US May 5, 2022